September 2022 // Company & Communication


Synendos Therapeutics is ranked TOP 100 Swiss Startups 2022


We are honored to be listed for the second year in a row as one of the TOP 100 Swiss Startups 2022. A big thank you to our team, partners, collaborators, and investors.

https://www.linkedin.com/feed/update/urn:li:activity:6973356870988128256


https://twitter.com/venturelab_ch/status/1567797207071334400

Recent Posts

See All

Synendos Therapeutics has been awarded with the Innosuisse Certificate Synendos has been awarded the Innosuisse certificate by Innosuisse Innovation Council. The Innosuisse certificate reflects remark

In a last newsletter edition from NCCR Transcure, we can look behind the scenes of our technology transfer success story.

Synendos Therapeutics is thrilled to announce the formation of the Scientific Advisory Board.